摘要
在哺乳动物肾细胞中发现的高亲和力、高特异性叶酸受体,具有结合叶酸受体介导的内吞作用叶酸进入细胞的能力,且叶酸受体在特定癌细胞类型中的过度表达,预示化疗叶酸靶向性的到来。纯有机叶酸基小分子药物缀合物选择性地靶向结合叶酸受体,其在多种疾病如癌症中过度表达的应用是公认的。无机叶酸靶向药物的应用为扩大和增强这种治疗方法提供了显著的潜力。由迄今为止所获得的数据来看,很明显,无机药物化学的这一方面的研究尚为年轻,但有能力对癌症研究做出巨大贡献,无论是在治疗和诊断方面。叶酸受体靶向与无机药物的结合也可能导致治疗慢性炎症、肺结核、神经退行性疾病和利什曼病等疾病的发展。在这篇综述中,我们总结了叶酸的配位化学和这种配合物的治疗潜力。我们还描述了将铂药物与叶酸或叶酸载体系统结合的方法,以及通过改善它们的递送和/或选择性来克服与不希望发生的的副作用和耐药性相关的问题的预期能力。有关非铂金属络合物与叶酸偶联物的文献也被回顾,揭示了这是一个领域,在诸如化学疗法和分子影像学诊断等领域开发有针对性的治疗方法具有重大潜力。
关键词: 金属叶酸配合物,叶酸受体靶向药物输送,化疗药物,诊断,DHFR
Current Medicinal Chemistry
Title:Targeting the Folate Receptor: Improving Efficacy in Inorganic Medicinal Chemistry
Volume: 25 Issue: 23
关键词: 金属叶酸配合物,叶酸受体靶向药物输送,化疗药物,诊断,DHFR
摘要: The discovery of the high-affinity, high-specificity folate receptor in mamalian kidney cells, coupled with the ability of folate to enter cells by folate receptor-mediated endocytosis and the subsequent elucidation of the folate receptor’s overexpression in specific cancer cell types; heralded the arrival of the area of chemotherapeutic folate targeting. The application of purely organic folate-based small-molecule drug conjugates that selectively target the folate receptor, which is over expressed in several diseases such as cancer, is well established. The application of inorganic folate-targeted drugs offers significant potential to expand and enhance this therapeutic approach. From the data made available to date, it is apparent that this aspect of inorganic medicinal chemistry is in its youth but has the capability to contribute greatly to cancer research, both in therapy and diagnosis. The union of folate-receptor targeting and inorganic medicine may also lead to the development of treatments for disorders such as chronic-inflammation, tuberculosis, neurodegenerative disease and leishmaniasis. In this review, we summarize what is known about the coordination chemistry of folic acid and the therapeutic potential of such complexes. We also describe approaches adopted to conjugate platinum drugs to folate- or folate-carrier- systems and their prospective ability to overcome problems associated with unwanted side-effects and resistance by improving their delivery and/or selectivity. The literature pertaining to non-platinum metal complex conjugates with folic acid is also reviewed revealing that this is an area that offers significant potential to develop targeted therapeutic approaches in areas such as chemotherapy and molecular imaging for diagnostics.
Export Options
About this article
Cite this article as:
Targeting the Folate Receptor: Improving Efficacy in Inorganic Medicinal Chemistry, Current Medicinal Chemistry 2018; 25 (23) . https://dx.doi.org/10.2174/0929867325666180209143715
DOI https://dx.doi.org/10.2174/0929867325666180209143715 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Nanostructured Therapeutic Carriers for Tuberculosis Treatment: Approaches & Challenges
Recent Patents on Anti-Infective Drug Discovery Homology Modeling of Adenosine A2A Receptor and Molecular Docking for Exploration of Appropriate Potent Antagonists for Treatment of Parkinsons Disease
Current Aging Science Chemokines: Central Mediators of the Innate Response to Sepsis
Current Immunology Reviews (Discontinued) Anti-Tumor Necrosis Factor-Alpha (TNF-α) Treatment Strategies in Crohns Disease
Recent Patents on Inflammation & Allergy Drug Discovery Complexities of Glucuronidation Affecting In Vitro-In Vivo Extrapolation
Current Drug Metabolism The Druggable Antimalarial Target PfDXR: Overproduction Strategies and Kinetic Characterization
Protein & Peptide Letters Autophagy: For Better or for Worse, in Good Times or in Bad Times …
Current Molecular Medicine Unusual Food Allergy: AlioideaAllergic Reactions Overview
Recent Patents on Inflammation & Allergy Drug Discovery Recent Advancement in the Diagnosis and Treatment of Leprosy
Current Topics in Medicinal Chemistry Current Treatment and Drug Discovery Against Leishmania spp. and Plasmodium spp.: A Review
Current Drug Targets The Aging of the Adaptive Immune System
Current Immunology Reviews (Discontinued) Idiopathic Transverse Myelitis and Neuromyelitis Optica: Clinical Profiles,Pathophysiology and Therapeutic Choices
Current Neuropharmacology Network-Based Strategies Can Help Mono- and Poly-pharmacology Drug Discovery: A Systems Biology View
Current Pharmaceutical Design Xanthine Oxidoreductase in Drug Metabolism: Beyond a Role as a Detoxifying Enzyme
Current Medicinal Chemistry Resveratrol Targets in Inflammation
Endocrine, Metabolic & Immune Disorders - Drug Targets Chromenopyridines: Promising Scaffolds for Medicinal and Biological Chemistry
Current Medicinal Chemistry Structure and Function of RNase AS: A Novel Virulence Factor From Mycobacterium tuberculosis
Current Medicinal Chemistry Immune Therapy for Infectious Diseases at the Dawn of the 21st Century: the Past, Present and Future Role of Antibody Therapy, Therapeutic Vaccination and Biological Response Modifiers
Current Pharmaceutical Design Inhaled Dry Powder Formulations for Treating Tuberculosis
Current Drug Delivery Current and New Strategies for the Delivery of Antiseptic Agents
Current Drug Delivery